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Rigberg et al have documented that the 30-day mortality rate
for elective thoracoabdominal aortic aneurysm (TAA) repair in
California from 1991 to 2002 was a sobering 19%. Furthermore,
an additional 12% of the patients died between 31 and 365 days,
for an overall 365-day mortality rate of 31%. Notably, this added
mortality for elective repair during the first year was not due to
in-hospital deaths not accounted for in the initial 30-day rate (see
Discussion following text). The elective mortality rate increased by
age group, with 30-day and 365-day rates in the oldest group (80
to 89 years) of 27% and 40%, respectively. Predictably, the mortal-
ity rates for the ruptured repair were significantly greater both
overall and per the different age groups. The authors’ findings are
consistent with several other nationwide reports documenting the
perioperativemortality after TAA repair, but contrast with the single-
institution reports from centers of excellence that have consistently
reported perioperative mortality rates of 10%.
Despite the limitations of the study (ie, retrospective design,
administrative database, limited clinical data, lack of control), the
poor results mandate re-evaluation of the clinical care delivery
system for patients with TAAs. First, the indications for operative
repair and the natural history of untreated TAAs likely need to be
further defined. The common recommendations for operative
repair range from a diameter of 5.5 to 6.5 cm, with Elefteriades1
reporting an annual combined rupture/dissection/mortality rate
of 14% for thoracic aortic aneurysms.
It is important, however, to remember that the elective repair
of a TAA is a prophylactic operation that is indicated when the risk
of rupture exceeds the risk of expectant or nonoperative manage-
ment. Although the size and extent of the aneurysms was not
available in the current study, it is unlikely that the annual rupture
risk exceeded the reported 365-day mortality rates, particularly for
the oldest subset of patients. Additionally, mortality was the onlyoutcome measure analyzed; but the associated risk of respiratory
failure, paraplegia, and renal failure are significant. Incorporation
of these additional adverse outcome measures into the analysis
would likely further undermine the role of TAA repair.
Second, the operative procedures should likely be concen-
trated in true “centers of excellence.” Hospital and provider pro-
cedural volumes have been related with outcome for almost every
major surgical procedure, and TAA repair is no exception. Indeed,
an experienced clinical delivery system for TAA repair is essential
given the complexity of the procedure from a surgical, anesthetic,
and critical care standpoint. It was surprising that 40% of the
procedures were performed at institutions that averaged a single
TAA repair per year, and no institution averaged more than 14
procedure per year.
Finally, alternative approaches for the repair of TAA should be
pursued. Black et al2 have recently documented their initial expe-
rience with a hybrid visceral revascularization and stent-graft repair
for TAA with an elective perioperative mortality of 18% and no
paraplegia. Furthermore, the worldwide experience with branch
endografts for TAA and suprarenal aneurysms is expanding rapidly,
and it may be possible to safely and effectively treat aneurysms
throughout the whole length of the aorta within a few years.
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